| pubmed-article:16719542 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16719542 | lifeskim:mentions | umls-concept:C0332174 | lld:lifeskim |
| pubmed-article:16719542 | lifeskim:mentions | umls-concept:C0877373 | lld:lifeskim |
| pubmed-article:16719542 | lifeskim:mentions | umls-concept:C0600688 | lld:lifeskim |
| pubmed-article:16719542 | lifeskim:mentions | umls-concept:C0246415 | lld:lifeskim |
| pubmed-article:16719542 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:16719542 | pubmed:dateCreated | 2006-5-24 | lld:pubmed |
| pubmed-article:16719542 | pubmed:abstractText | To determine the safety profile of 40 mg/m(2) docetaxel administered weekly to a mixed population of advanced cancer patients and identify predictors of toxicity and survival following treatment with weekly docetaxel in this population. | lld:pubmed |
| pubmed-article:16719542 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16719542 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16719542 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16719542 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16719542 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16719542 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16719542 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16719542 | pubmed:issn | 0312-5963 | lld:pubmed |
| pubmed-article:16719542 | pubmed:author | pubmed-author:RivoryLaurent... | lld:pubmed |
| pubmed-article:16719542 | pubmed:author | pubmed-author:ClarkeStephen... | lld:pubmed |
| pubmed-article:16719542 | pubmed:author | pubmed-author:BealePhilipP | lld:pubmed |
| pubmed-article:16719542 | pubmed:author | pubmed-author:BoyerMichaelM | lld:pubmed |
| pubmed-article:16719542 | pubmed:author | pubmed-author:StocklerMarti... | lld:pubmed |
| pubmed-article:16719542 | pubmed:author | pubmed-author:CharlesKellie... | lld:pubmed |
| pubmed-article:16719542 | pubmed:author | pubmed-author:BeithJaneJ | lld:pubmed |
| pubmed-article:16719542 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16719542 | pubmed:volume | 45 | lld:pubmed |
| pubmed-article:16719542 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16719542 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16719542 | pubmed:pagination | 611-22 | lld:pubmed |
| pubmed-article:16719542 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16719542 | pubmed:meshHeading | pubmed-meshheading:16719542... | lld:pubmed |
| pubmed-article:16719542 | pubmed:meshHeading | pubmed-meshheading:16719542... | lld:pubmed |
| pubmed-article:16719542 | pubmed:meshHeading | pubmed-meshheading:16719542... | lld:pubmed |
| pubmed-article:16719542 | pubmed:meshHeading | pubmed-meshheading:16719542... | lld:pubmed |
| pubmed-article:16719542 | pubmed:meshHeading | pubmed-meshheading:16719542... | lld:pubmed |
| pubmed-article:16719542 | pubmed:meshHeading | pubmed-meshheading:16719542... | lld:pubmed |
| pubmed-article:16719542 | pubmed:meshHeading | pubmed-meshheading:16719542... | lld:pubmed |
| pubmed-article:16719542 | pubmed:meshHeading | pubmed-meshheading:16719542... | lld:pubmed |
| pubmed-article:16719542 | pubmed:meshHeading | pubmed-meshheading:16719542... | lld:pubmed |
| pubmed-article:16719542 | pubmed:meshHeading | pubmed-meshheading:16719542... | lld:pubmed |
| pubmed-article:16719542 | pubmed:meshHeading | pubmed-meshheading:16719542... | lld:pubmed |
| pubmed-article:16719542 | pubmed:meshHeading | pubmed-meshheading:16719542... | lld:pubmed |
| pubmed-article:16719542 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16719542 | pubmed:articleTitle | Predicting the toxicity of weekly docetaxel in advanced cancer. | lld:pubmed |
| pubmed-article:16719542 | pubmed:affiliation | Department of Pharmacology, University of Sydney, Sydney, NSW, Australia. sclarke@med.usyd.edu.au | lld:pubmed |
| pubmed-article:16719542 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16719542 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:16719542 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
